Haemonetics Reports Fiscal Second-Quarter Earnings
Haemonetics reported fiscal second-quarter earnings.
Related stories
Lemonade Raises GEP and Revenue Guidance, Expects Positive Q4 Adjusted EBITDA
Lemonade reiterated its FY IFP guidance and raised its GEP and revenue guidance. It expects positive adjusted EBITDA in Q4 2026.
M impact | EQUITY | Nov 05, 2026, 11:29 AM UTC
Lemonade Q3 Revenue Beats Estimates on Premium Growth
M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC
AtkinsRealis Reports Q3 Revenue of CA$3.11B
AtkinsRealis Group reported Q3 revenue of CA$3.11B, versus a FactSet estimate of CA$3.02B.
M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC
Titan Co Approves Proposal for NCDs Up to 25 Billion Rupees
M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC
Toyota Raises FY Share Repurchase Limit to ¥1.3 Trillion, Adds Tender Offer
Toyota's board amended its August buyback plan, raising the total repurchase limit by ¥300 billion to ¥1.3 trillion and adding a tender offer.
M impact | EQUITY | Nov 05, 2026, 11:22 AM UTC
Asian Tech Stocks Reflect Changing AI Trade, Research Firm Says
Citrini Research says the AI trade is evolving, and Asian tech stocks reflected the shift on Thursday.
M impact | EQUITY | Nov 05, 2026, 11:22 AM UTC